Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AxoGen

AxoGen
2002 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
AXGN STOCK SYMBOL
1 INVESTMENTS
$14.31 SHARE PRICE (As of Friday Closing)
Description

Axogen Inc is a medical technology company. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. The firm's product portfolio includes Avance nerve graft, Axoguard nerve connector and nerve protector, Avive soft tissue membrane, Axotouch two-point membrane and Acroval Neurosensory and motor testing system. Its products are available in the United States, Canada, the United Kingdom and other European and International countries. The company generates the majority of its sales in the United States.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 13631 Progress Boulevard
  • Suite 400
  • Alachua, FL 32615
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AxoGen’s full profile, request a free trial.

AxoGen Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$10.91 - $25.84 $565M $15.02 -$0.69 363K 39.5M

AxoGen Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 391,053 663,792 971,926 305,076
Revenue 101,983 83,937 60,426 41,108
EBITDA (25,002) (20,338) (7,415) (7,713)
Net Income (27,326) (22,397) (10,445) (14,411)
Total Assets 154,192 160,173 58,875 46,360
Total Debt 3,775 63 24,545 24,312
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AxoGen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore AxoGen‘s full profile, request access.

Request full access to PitchBook

AxoGen Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Private Equity-Backed Winston-Salem, NC 00 00000 000000&0
To view this company’s complete list of competitors, request access »

AxoGen Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 30-Sep-2011 000000000000000000 0000 Therapeutic Devices 00000 0000000
To view this company’s complete investment and acquisition history, request access »

AxoGen Subsidiaries (1)

Company Name Industry Location Founded
000000 Therapeutic Devices Texarkana, TX 0000
To view this company’s complete subsidiary history, request access »

AxoGen Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore AxoGen‘s full profile, request access.

Request full access to PitchBook

AxoGen Executive Team (15)

Name Title Board
Seat
Contact
Info
Karen Zaderej Chief Executive Officer & Chairman
Peter Mariani Chief Financial Officer & Chief Accounting Officer
Maria Martinez Chief Human Resources Officer
Isabelle Billet Chief Strategy and Business Development Officer
Gregory Freitag JD Board Member & General Counsel

4 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

AxoGen Board Members (12)

Name Representing Role Since Contact
Info
Amy Wendell AxoGen Board Member 000 0000
Gregory Freitag JD AxoGen Board Member & General Counsel 000 0000
Guido Neels EW Healthcare Partners Board Member 000 0000
Karen Zaderej AxoGen Chief Executive Officer & Chairman 000 0000
Mark Gold MD Self Board Member 000 0000

5 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »